Edgell, Eric T.; Andersen, Scott W.; Johnstone, Bryan M.; … - In: PharmacoEconomics 18 (2000) 6, pp. 567-579
Objective: To compare the clinical and economic outcomes associated with olanzapine and risperidone treatment for schizophrenia. Design and setting: An international, multicentre, double-blind, prospective study. To facilitate economic comparisons, our sample was restricted to patients enrolled...